Rangeley Capital, LLC
Source: SEC Form 13F · as of Mar 2026Rangeley Capital, LLC holds 24 biotech & pharma companies tracked by BioSniper, totaling $18.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$18.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for PROTHENA CORP PUBLIC LTD CO (PRTA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PRTAPROTHENA CORP PUBLIC LTD CO | 449,460 | $4.4M |
| ARVNARVINAS, INC. | 223,990 | $2.4M |
| ABUSArbutus Biopharma Corp | 500,000 | $2.3M |
| KZRKezar Life Sciences, Inc. | 243,073 | $1.8M |
| RVMDREVOLUTION MEDICINES, INC. | 66,700 | $1.2M |
| BCYCBICYCLE THERAPEUTICS PLC | 232,260 | $1.1M |
| KURAKura Oncology, Inc. | 101,220 | $823K |
| KROSKeros Therapeutics, Inc. | 54,400 | $601K |
| ABVXAbivax SA | 4,000 | $445K |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 44,840 | $421K |
| OKUROnKure Therapeutics, Inc. | 95,000 | $393K |
| ACETAdicet Bio, Inc. | 56,000 | $381K |
| LSTALISATA THERAPEUTICS, INC. | 75,000 | $376K |
| CNTACentessa Pharmaceuticals plc | 9,000 | $357K |
| FDMT4D Molecular Therapeutics, Inc. | 31,465 | $293K |
| PLRXPLIANT THERAPEUTICS, INC. | 225,000 | $284K |
| RLYBRallybio Corp | 30,130 | $270K |
| ABEOABEONA THERAPEUTICS INC. | 60,000 | $269K |
| EXELEXELIXIS, INC. | 5,000 | $214K |
| QUREuniQure N.V. | 13,000 | $213K |
| IMAImageneBio, Inc. | 32,590 | $163K |
| RZLTRezolute, Inc. | 40,000 | $122K |
| BRNSBarinthus Biotherapeutics plc. | 159,465 | $91K |
| IVVDInvivyd, Inc. | 45,000 | $59K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.